VIKING GLOBAL INVESTORS LP → BridgeBio Pharma, Inc. BBIO

Stake: 6.10% Shares: 11,842,434 CUSIP: 10806X102 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 5(c) of this Amendment No. 11 is incorporated by reference herein.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 14.73

23,366,752 shares short · -0.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $581K

Point72 Asset Mgmt

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →